Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05378347 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

Study acronym: ADVANCE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 2 of 68 sitesv30
  2. Enrollment target: 550 to 600
    • Eligibility criteria expanded, about 8 words
    • Study description shortened, about 27 words
    • Site details revised at 2 of 68 sites
    v29
  3. Study sites: 67 to 68v28
  4. Study sites: 66 to 67v27
  5. Site details revised at 2 of 66 sitesv26
Show 24 earlier versionsHide 24 earlier versions
  1. Study sites: 64 to 66v25
  2. Primary completion date: May 2025 to May 2027
    • Study completion date: May 2029 to May 2031
    v24
  3. Study sites: 62 to 64v23
  4. Study sites: 59 to 62v22
  5. Study sites: 57 to 59v21
  6. Study sites: 54 to 57v20
  7. Study sites: 52 to 54v19
  8. Study sites: 51 to 52v18
  9. Study sites: 49 to 51v17
  10. Study sites: 43 to 49v16
  11. Study sites: 38 to 43v15
  12. Study sites: 32 to 38
    • Study description expanded, about 39 words
    v14
  13. Study sites: 30 to 32
    • Eligibility criteria expanded, about 18 words
    • Study description shortened, about 3 words
    v13
  14. Study sites: 27 to 30v12
  15. Study sites: 22 to 27v11
  16. Study sites: 13 to 22v10
  17. Study sites: 10 to 13v9
  18. Study sites: 6 to 10v8
  19. Study sites: 5 to 6
    • Start date changed from estimate of Dec 6, 2022 to Jan 5, 2023
    v7
  20. Start date: Oct 28, 2022 to Dec 6, 2022
    • Study sites: 4 to 5
    v6
  21. Study sites: 3 to 4
    • Start date: Sep 2022 to Oct 28, 2022
    v5
  22. Study sites: 2 to 3
    • Start date: Aug 2022 to Sep 2022
    v4
  23. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date: Jul 2022 to Aug 2022
    • Study title shortened, about 9 words
    v3
  24. Study title revisedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.
Trial Details
NCT Number NCT05378347
Lead Sponsor Medtronic Cardiovascular
Conditions
(from sponsor)		 Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Related terms Aortic Aneurysm, Abdominal
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov